PapersPMID:29747663
The lipid-lowering effects of Danhong and Huangqi injections: a meta-analysis of clinical controlled trials.
- findings
- 3
- compound
- 1
- endpoints
- 3
- no difference found
- 2
- Study, every finding
- meta-analysis
What moved
How to read these marks →- Decreases total cholesterol (TC)
moderate
“The outcomes of the analysis on all studies showed that Huangqi injection could significantly decrease TC levels [SMD = − 1.13, 95% CI = (− 2.09, − 0.16), P = 0.02], and marginally significantly decrease TG levels [SMD = − 1.27, 95% CI = (− 2.53, 0.00), P = 0.05].”
- Effect
- −1.13 standardised mean difference, 95% CI −2.09 to −0.16
- Dose studied
- high dose (40 mL or more) in 4 trials, low dose (under 40 mL) in 3 trials
- Population
- Meta-analysis of 7 controlled trials (542 subjects, all Chinese, 5 of the 7 in nephrotic syndrome) of Huangqi injection added to control treatment versus control treatment alone
What did not
“Huangqi injection did not have significant effects on the changes in LDL-C and HDL-C levels (Table 2 and Fig. 5).”
- Population
- Meta-analysis of 3 controlled trials (220 subjects, all Chinese) of Huangqi injection added to control treatment versus control treatment alone
- Population
- Meta-analysis of 3 controlled trials (220 subjects, all Chinese) of Huangqi injection added to control treatment versus control treatment alone
Study record
- Design
- meta-analysis
- Species
- human
- Population
- Chinese subjects with coronary heart disease, stroke, hyperlipidemia, diabetes, nephrotic syndrome or hypertension
- Participants
- not reported
- Comparator
- no treatment
- Duration
- not reported
- Endpoints measured
- 50